Alabama, North Dakota and South Carolina were the first states to announce plans to develop contact tracing apps that would use a framework developed by Apple and Google. Apple and Google launched their exposure notification API on Wednesday.
Discovery Benefits provides account administration for consumer-directed benefits like flexible savings accounts and health savings accounts.
AI-native tax firm Gelt combines top human tax experts with AI to help physicians and healthcare practices use data-driven tax strategies to lower liabilities, improve profitability, and future-proof their finances.
Students at the University of North Dakota are getting real experience in venture capital and angel investing - currently the first program of its kind in the U.S.
N.D.–Patients will benefit from improved treatment for cancer and other conditions with the use of new high-tech equipment that more precisely targets cancerous tumors, according to Dr. Grant R. Seeger, radiation oncologist at the Altru Cancer Center in Grand Forks. The linear accelerator, valued at $3 million, was moved into the building’s basement on Wednesday. […]
Whereas most vaccines under development are designed to protect against one kind of pathogen, NovaDigm Therapeutics thinks a vaccine it’s developing could protect against certain fungal and bacterial infections caused by several species of the fungus Candida. NovaDigm will be able to test its hypothesis thanks to a new 14 million Series B from RusnanoMedInvest, […]
In Alabama, if you get your health insurance through your employer and you lose your job, you quickly realize there aren't a lot options for purchasing coverage on your own. Blue Cross and Blue Shield of Alabama has had a virtual monopoly in the state ...
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.
A clinical-stage pharmaceutical company with a vaccine it says uses a single antigen to protect against both fungal and bacterial infections is looking for a series B round to fund phase 2 trials for hospital-associated infection and women’s health applications next year. NovaDigm Therapeutics’ lead product, the NDV-3 vaccine, targets the fungal infection candida and […]
This post is sponsored by Fargo Moorhead Economic Development Corporation. Satish Chandran looked at Fargo, N.D., three years ago and saw opportunity. The potential was so enticing, in fact, that he left pharma giant Pfizer in 2010 to build it. Today, as the director of the North Dakota Center for Biopharmaceutical Research and Production (CBRP), […]